ELVN

Conviction 44HealthcareScan · Thu, Sep 24, 2026

Enliven Therapeutics, Inc. (ELVN) closed at $45.13 (-2.08%) on Sep 24, 2026. Price is below its 50-day and above its 200-day moving average. RSI(14) 21, RS Rating 95, -26.2% from its 52-week high, +190.4% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

ELVN$45.13-2.08%

ResistanceSupportVol 14Insider sell

Vol MA14 1.85M

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

Enliven Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.enliventherapeutics.com ↗

Price45.13

Change-2.08%

Gap-0.10%

Rel volume1.87×

Avg volume1.52M

Avg $ vol78.93M

SMA 2054.22

SMA 5055.89

SMA 20039.60

Price vs 50-19.25%

Price vs 200+13.97%

MA stackmixed

50/200 cross—

Supertrenddown · 52.03

RSI (14)21

MACD hist-1.21

MACD cross—

Stoch %K / %D2 / 3

ADX (14)38

+DI / −DI8 / 39

RSI divergence—

MACD divergence—

ATR %4.91%

ADR %4.05%

52w high61.15

52w low15.14

From 52w high-26.20%

Above 52w low+198.08%

New 52w highNo

SqueezeOff

Bollinger width36.07%

%B0.04

Donchian pos1.62%

Donchian high61.82

Donchian low44.86

AVWAP (52w high)54.72

vs AVWAP high-17.53%

AVWAP (52w low)41.65

vs AVWAP low+8.36%

OBV trendDown

Chaikin MF (20)-0.44

Today vs 20d1.87×

Avg vol (14d)1.85M

Avg vol (20d)1.52M

Avg $ vol (20d)78.93M

Market cap3.31B

RS Rating95 / 99

RS 3m (vs SPY)-12.61%

RS 6m (vs SPY)+10.20%

RS line new highNo

Trend template4/8

Technical rank50.9

1 week-10.17%

1 month-26.03%

3 months-8.12%

6 months+27.02%

1 year+135.17%

YTD+190.41%

P/E-31.89

P/B3.69

P/S—

P/FCF-46.93

EPS-1.83

Div yield—

ROE-11.58%

ROA-11.39%

Debt/Eq—

Current64.07

EV/EBITDA-26.57

Gross margin—

Net margin—

Rev growth—

EPS growth-16.48%

Price target73.90

Target upside63.75%

Analyst ratingBuy

Institutional113.31%

Ent. value3.17B

Revenue—

Net income-32.48M

Gross profit—

Free cash flow-70.46M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out60.9M

Employees61

ListedFri, Feb 24, 2023

Free float45.39M

Float %76.5%

Short interest8.6M

Days to cover11.1d

Short volume70.8%

Squeeze score96 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.49 vs −$0.38

Last surprise-28.9% miss

Setup gradeD

Conviction44 / 100

Pattern quality—

Tech rank50.9 / 100

Group rank59 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance62.16

Support50.58

Days since event—

Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ELVN

All disclosures →

No recent disclosed trades by Congress in ELVN. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ELVN · open-market 6 sells

Insider	Side	Shares	Value	Traded	Filed
Collins Helen Louise CHIEF MEDICAL OFFICER · Common Stock · 2026-09-17	Exercise	5K	$12K	2026-09-17	2026-09-21
Collins Helen Louise CHIEF MEDICAL OFFICER · Common Stock · 2026-09-17	Sell	2.92K	$146K	2026-09-17	2026-09-21
Collins Helen Louise CHIEF MEDICAL OFFICER · Common Stock · 2026-09-17	Sell	1.84K	$94K	2026-09-17	2026-09-21
Collins Helen Louise CHIEF MEDICAL OFFICER · Common Stock · 2026-09-17	Sell	240	$12K	2026-09-17	2026-09-21
Collins Helen Louise CHIEF MEDICAL OFFICER · Stock Option (right to buy) · 2026-09-17	Exercise	5K	—	2026-09-17	2026-09-21
Hohl Benjamin CHIEF FINANCIAL OFFICER · Common Stock · 2026-09-17	Exercise	3.98K	$59K	2026-09-17	2026-09-21
Hohl Benjamin CHIEF FINANCIAL OFFICER · Common Stock · 2026-09-17	Sell	3.54K	$177K	2026-09-17	2026-09-21
Hohl Benjamin CHIEF FINANCIAL OFFICER · Common Stock · 2026-09-17	Sell	2.19K	$111K	2026-09-17	2026-09-21
Hohl Benjamin CHIEF FINANCIAL OFFICER · Common Stock · 2026-09-17	Sell	289	$15K	2026-09-17	2026-09-21
Hohl Benjamin CHIEF FINANCIAL OFFICER · Stock Option (right to buy) · 2026-09-17	Exercise	3.98K	—	2026-09-17	2026-09-21

SEC filings

EDGAR filings in ELVN · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.

ELVN

Recent news

Get daily signals & real-time alerts.